Open Government Portal

Appearance before the House of Commons Standing Committee on Health (HESA) on health research pertaining to COVID-19

Briefing package for the President of the National Research Council as witness before the Standing Committee on Health (HESA) on February 22, 2021 on the topic of the Emergency Situation Facing Canadians in Light of the Second Wave of the COVID‑19 Pandemic.

Briefing material for the President of the Public Health Agency of Canada’s appearance at the Standing Committee on Health (HESA) of May 2, 2022

Briefing package for the President of the Canadian Food Inspection Agency as witness before the Standing Committee on Health (HESA) on February 5, 2021 on the topic of COVID-19 – Vaccines Rollout

Briefing binder used by the Privacy Commissioner of Canada, Daniel Therrien, as a witness before HESA on June 23, 2021 on the Emergency Situation Facing Canadians in Light of the COVID-19 Pandemic.

Supplementary estimates (B) 2020-21 CIHR

TRANSFERS FROM HEALTH CANADA TO THE CANADIAN INSTITUTES OF HEALTH RESEARCH TO SUPPORT
APPROACHES FOR TESTING – TABLING OF THE 2020–21 SUPPLEMENTARY ESTIMATES (C)

The International Surveillance Border Study by McMaster Health Labs is designed to determine the
effectiveness of an airport-based COVID-19 surveillance program, and inform effective testing and
quarantine models.

The importance of research and the Canadian Institutes
of Health Research (CIHR)’s pivotal role in Canada’s
response to COVID-19.

Canadians and people around the world are expecting the international research
community to quickly develop and rollout safe vaccines and therapies to deal with
the COVID-19 pandemic and return to a more normal life.